ICPT
Macquarie Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,000
| Closed | -$501K | – | 1702 |
|
|
2023
Q3 | $501K | Hold |
27,000
| – | – | ﹤0.01% | 1440 |
|
|
2023
Q2 | $299K | Sell |
27,000
-659,267
| -96% | -$7.3M | ﹤0.01% | 1509 |
|
|
2023
Q1 | $9.22M | Buy |
686,267
+14,272
| +2% | +$192K | 0.01% | 819 |
|
|
2022
Q4 | $8.31M | Buy |
671,995
+16,055
| +2% | +$199K | 0.01% | 873 |
|
|
2022
Q3 | $9.16M | Buy |
655,940
+10,871
| +2% | +$152K | 0.01% | 847 |
|
|
2022
Q2 | $8.91M | Buy |
645,069
+24,398
| +4% | +$337K | 0.01% | 898 |
|
|
2022
Q1 | $10.1K | Buy |
620,671
+3,174
| +0.5% | +$52 | 0.01% | 933 |
|
|
2021
Q4 | $10.1M | Sell |
617,497
-3,915
| -0.6% | -$63.8K | 0.01% | 933 |
|
|
2021
Q3 | $9.23M | Sell |
621,412
-54,798
| -8% | -$814K | 0.01% | 943 |
|
|
2021
Q2 | $13.5M | Buy |
676,210
+10,448
| +2% | +$209K | 0.01% | 867 |
|
|
2021
Q1 | $15.4M | Sell |
665,762
-38,922
| -6% | -$898K | 0.02% | 616 |
|
|
2020
Q4 | $17.4M | Sell |
704,684
-74,275
| -10% | -$1.83M | 0.03% | 562 |
|
|
2020
Q3 | $32.3M | Buy |
778,959
+10,915
| +1% | +$453K | 0.05% | 357 |
|
|
2020
Q2 | $36.8M | Buy |
768,044
+52,830
| +7% | +$2.53M | 0.06% | 318 |
|
|
2020
Q1 | $45M | Buy |
715,214
+169,800
| +31% | +$10.7M | 0.09% | 237 |
|
|
2019
Q4 | $67.6M | Buy |
545,414
+183,072
| +51% | +$22.7M | 0.1% | 221 |
|
|
2019
Q3 | $24M | Buy |
362,342
+322,971
| +820% | +$21.4M | 0.04% | 413 |
|
|
2019
Q2 | $3.13M | Buy |
39,371
+2,086
| +6% | +$166K | 0.01% | 893 |
|
|
2019
Q1 | $4.17M | Buy |
37,285
+758
| +2% | +$84.8K | 0.01% | 823 |
|
|
2018
Q4 | $3.68M | Buy |
36,527
+966
| +3% | +$97.4K | 0.01% | 824 |
|
|
2018
Q3 | $4.49M | Buy |
35,561
+21,819
| +159% | +$2.76M | 0.01% | 812 |
|
|
2018
Q2 | $1.15M | Buy |
13,742
+4,062
| +42% | +$341K | ﹤0.01% | 1142 |
|
|
2018
Q1 | $596K | Sell |
9,680
-88
| -0.9% | -$5.42K | ﹤0.01% | 1329 |
|
|
2017
Q4 | $571K | Buy |
9,768
+4,768
| +95% | +$279K | ﹤0.01% | 1400 |
|
|
2017
Q3 | $290K | Sell |
5,000
-232,431
| -98% | -$13.5M | ﹤0.01% | 1630 |
|
|
2017
Q2 | $28.7M | Sell |
237,431
-4,134
| -2% | -$501K | 0.05% | 348 |
|
|
2017
Q1 | $27.3M | Buy |
241,565
+84,954
| +54% | +$9.61M | 0.05% | 372 |
|
|
2016
Q4 | $17M | Sell |
156,611
-209,801
| -57% | -$22.8M | 0.03% | 485 |
|
|
2016
Q3 | $60.3M | Buy |
366,412
+321,032
| +707% | +$52.8M | 0.12% | 143 |
|
|
2016
Q2 | $6.47M | Buy |
45,380
+35,478
| +358% | +$5.06M | 0.01% | 813 |
|
|
2016
Q1 | $1.27M | Buy |
9,902
+6,012
| +155% | +$772K | ﹤0.01% | 1066 |
|
|
2015
Q4 | $581K | Sell |
3,890
-13,514
| -78% | -$2.02M | ﹤0.01% | 1155 |
|
|
2015
Q3 | $2.89M | Sell |
17,404
-3,446
| -17% | -$572K | 0.01% | 879 |
|
|
2015
Q2 | $5.03M | Buy |
20,850
+1,600
| +8% | +$386K | 0.01% | 737 |
|
|
2015
Q1 | $5.43M | Buy |
19,250
+9,000
| +88% | +$2.54M | 0.01% | 722 |
|
|
2014
Q4 | $1.6M | Sell |
10,250
-1,450
| -12% | -$226K | ﹤0.01% | 1071 |
|
|
2014
Q3 | $2.77M | Sell |
11,700
-350
| -3% | -$82.8K | 0.01% | 894 |
|
|
2014
Q2 | $2.85M | Buy |
12,050
+5,550
| +85% | +$1.31M | 0.01% | 916 |
|
|
2014
Q1 | $2.14M | Buy |
+6,500
| New | +$2.14M | ﹤0.01% | 997 |
|